FI101148B - Parannettu menetelmä 4-£2-(di-n-propyyliamino)etyyli|-1,3-dihydro-2H-i ndol-2-onin valmistamiseksi ja uusi välituote - Google Patents

Parannettu menetelmä 4-£2-(di-n-propyyliamino)etyyli|-1,3-dihydro-2H-i ndol-2-onin valmistamiseksi ja uusi välituote

Info

Publication number
FI101148B
FI101148B FI924674A FI924674A FI101148B FI 101148 B FI101148 B FI 101148B FI 924674 A FI924674 A FI 924674A FI 924674 A FI924674 A FI 924674A FI 101148 B FI101148 B FI 101148B
Authority
FI
Finland
Prior art keywords
preparation
pct
propylamino
indol
dihydro
Prior art date
Application number
FI924674A
Other languages
English (en)
Swedish (sv)
Other versions
FI924674A0 (fi
FI924674A (fi
Inventor
Robert Giles
Timothy Charles Walsgrove
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of FI924674A0 publication Critical patent/FI924674A0/fi
Publication of FI924674A publication Critical patent/FI924674A/fi
Priority to FI960929A priority Critical patent/FI102533B/fi
Application granted granted Critical
Publication of FI101148B publication Critical patent/FI101148B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/39Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by esterified hydroxy groups
    • C07C205/40Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by esterified hydroxy groups having nitro groups and esterified hydroxy groups bound to acyclic carbon atoms of the carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C201/00Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
    • C07C201/06Preparation of nitro compounds
    • C07C201/12Preparation of nitro compounds by reactions not involving the formation of nitro groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/78Benzoic acid esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI924674A 1990-04-17 1992-10-15 Parannettu menetelmä 4-£2-(di-n-propyyliamino)etyyli|-1,3-dihydro-2H-i ndol-2-onin valmistamiseksi ja uusi välituote FI101148B (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI960929A FI102533B (fi) 1990-04-17 1996-02-28 4-(2'-substituoidut etyyli)-1,3-dihydro-2H-indol-2-oniyhdisteet

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909008605A GB9008605D0 (en) 1990-04-17 1990-04-17 Process
PCT/GB1991/000587 WO1991016306A1 (en) 1990-04-17 1991-04-15 An improved process for the preparation of substituted indolone derivatives

Publications (3)

Publication Number Publication Date
FI924674A0 FI924674A0 (fi) 1992-10-15
FI924674A FI924674A (fi) 1992-10-15
FI101148B true FI101148B (fi) 1998-04-30

Family

ID=10674534

Family Applications (1)

Application Number Title Priority Date Filing Date
FI924674A FI101148B (fi) 1990-04-17 1992-10-15 Parannettu menetelmä 4-£2-(di-n-propyyliamino)etyyli|-1,3-dihydro-2H-i ndol-2-onin valmistamiseksi ja uusi välituote

Country Status (29)

Country Link
US (1) US5336781A (fi)
EP (1) EP0526529B1 (fi)
JP (2) JP2788548B2 (fi)
KR (1) KR0180215B1 (fi)
CN (1) CN1027892C (fi)
AP (1) AP184A (fi)
AT (1) ATE144251T1 (fi)
AU (2) AU640006B2 (fi)
CA (1) CA2080221C (fi)
CY (1) CY1981A (fi)
DE (1) DE69122753T2 (fi)
DK (1) DK0526529T3 (fi)
ES (1) ES2094812T3 (fi)
FI (1) FI101148B (fi)
GB (1) GB9008605D0 (fi)
GR (1) GR3022261T3 (fi)
HK (1) HK3097A (fi)
HU (1) HU214822B (fi)
IE (1) IE911262A1 (fi)
IL (7) IL97867A (fi)
MA (1) MA22133A1 (fi)
MY (1) MY109628A (fi)
NO (2) NO178396C (fi)
NZ (1) NZ237819A (fi)
PL (1) PL166736B1 (fi)
PT (1) PT97375B (fi)
SA (1) SA91110352B1 (fi)
WO (1) WO1991016306A1 (fi)
ZA (1) ZA912782B (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9008605D0 (en) * 1990-04-17 1990-06-13 Smith Kline French Lab Process
CZ51593A3 (en) * 1990-09-28 1994-01-19 Smithkline Beecham Corp Water-soluble analogs of camptothecine, process of their preparation and use
GB9300309D0 (en) * 1993-01-08 1993-03-03 Smithkline Beecham Plc Process
US6218421B1 (en) * 1999-07-01 2001-04-17 Smithkline Beecham P.L.C. Method of promoting smoking cessation
AR030557A1 (es) 2000-04-14 2003-08-27 Jagotec Ag Una tableta en multicapa de liberacion controlada y metodo de tratamiento
WO2005074387A2 (en) * 2003-12-30 2005-08-18 Sun Pharmaceutical Industries Limited Novel crystal forms of 4-[2-di-n-propylamino)ethyl]-2 (3h)- indolone hydrochloride
US7378439B2 (en) * 2004-01-20 2008-05-27 Usv, Ltd. Process for the preparation of 4-(2-dipropylaminoethyl)-1,3-dihydro-2H-indol-2-one hydrochloride
WO2005105741A1 (en) * 2004-02-11 2005-11-10 Sun Pharmaceutical Industries Limited Substantially pure 4-[2-(di-n-propylamino)ethyl]-2(3h)-indolone hydrochloride
WO2005080333A1 (en) * 2004-02-19 2005-09-01 Torrent Pharmaceuticals Ltd Process for purification of ropinirole
US20070254941A1 (en) * 2006-04-21 2007-11-01 Glenmark Pharmaceuticals Limited Subtantially pure ropinirole hydrochloride, polymorphic form of ropinirole and process for their preparation
CN103130704B (zh) * 2013-03-11 2019-03-22 上海奥博生物医药技术有限公司 一种制备4-(2-羟乙基)-1,3-二氢-2h-吲哚-2-酮的新方法
CN103145604A (zh) * 2013-03-19 2013-06-12 上海奥博生物医药技术有限公司 一种制备罗匹尼罗关键中间体的方法
CN105418482A (zh) * 2015-11-23 2016-03-23 东南大学 一种改进的盐酸罗匹尼罗的制备方法
CN108440376B (zh) * 2018-05-08 2020-06-05 中国科学院成都生物研究所 一种盐酸罗匹尼罗的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1154976A (en) * 1967-02-21 1969-06-11 Pfizer Ltd N-Phenyl Indoline Derivatives
JPS53101333A (en) * 1977-02-14 1978-09-04 Sagami Chem Res Center 3-acyloxymethyl-3,4:5,6-diepoxycyclohexane-1,2-diol and
IT1171624B (it) * 1980-11-12 1987-06-10 Thomae Gmbh Dr K Indolinoni dotati di proprieta' farmaceutiche e procedimento per la loro produzione
US4588790A (en) * 1982-03-24 1986-05-13 Union Carbide Corporation Method for fluidized bed polymerization
US4452808A (en) * 1982-12-07 1984-06-05 Smithkline Beckman Corporation 4-Aminoalkyl-2(3H)-indolones
US4593033A (en) * 1985-04-24 1986-06-03 Merck & Co., Inc. Substituted indeno[2,1-c] pyridines useful as calcium channel blockers
GB8712073D0 (en) * 1987-05-21 1987-06-24 Smith Kline French Lab Medicament
GB8714371D0 (en) * 1987-06-19 1987-07-22 Smith Kline French Lab Process
FR2635104B1 (fr) * 1988-08-03 1992-04-30 Synthelabo Derives d'indolone, leur preparation et leur application en therapeutique
GB9008605D0 (en) * 1990-04-17 1990-06-13 Smith Kline French Lab Process

Also Published As

Publication number Publication date
NO1999012I1 (no) 1999-06-18
ES2094812T3 (es) 1997-02-01
US5336781A (en) 1994-08-09
IL97867A0 (en) 1992-06-21
NO924028L (no) 1992-10-16
IL111030A0 (en) 1994-11-28
DE69122753T2 (de) 1997-05-07
ATE144251T1 (de) 1996-11-15
CA2080221A1 (en) 1991-10-18
JPH10251205A (ja) 1998-09-22
CA2080221C (en) 2000-11-14
JP3044013B2 (ja) 2000-05-22
DK0526529T3 (da) 1996-11-18
PT97375B (pt) 1998-08-31
NO924028D0 (no) 1992-10-16
PT97375A (pt) 1992-01-31
CN1056686A (zh) 1991-12-04
JPH05506029A (ja) 1993-09-02
IE911262A1 (en) 1991-10-23
GR3022261T3 (en) 1997-04-30
IL111028A (en) 1995-11-27
AP9100251A0 (en) 1991-04-30
HU9203261D0 (en) 1992-12-28
AU3566993A (en) 1993-06-03
HK3097A (en) 1997-01-10
CN1027892C (zh) 1995-03-15
EP0526529B1 (en) 1996-10-16
CY1981A (en) 1997-09-05
IL111029A (en) 1995-11-27
AU7656291A (en) 1991-11-11
EP0526529A1 (en) 1993-02-10
IL111030A (en) 1995-11-27
NO178396C (no) 1996-03-20
ZA912782B (en) 1992-11-25
DE69122753D1 (de) 1996-11-21
NZ237819A (en) 1993-05-26
MA22133A1 (fr) 1991-12-31
PL166736B1 (pl) 1995-06-30
MY109628A (en) 1997-03-31
IL111028A0 (en) 1994-11-28
GB9008605D0 (en) 1990-06-13
FI924674A0 (fi) 1992-10-15
HUT64742A (en) 1994-02-28
HU214822B (hu) 1998-06-29
SA91110352B1 (ar) 2001-11-12
WO1991016306A1 (en) 1991-10-31
AU646771B2 (en) 1994-03-03
FI924674A (fi) 1992-10-15
IL111029A0 (en) 1994-11-28
AU640006B2 (en) 1993-08-12
IL97867A (en) 1995-11-27
NO178396B (no) 1995-12-11
KR0180215B1 (ko) 1999-03-20
JP2788548B2 (ja) 1998-08-20
AP184A (en) 1992-06-30

Similar Documents

Publication Publication Date Title
FI101148B (fi) Parannettu menetelmä 4-£2-(di-n-propyyliamino)etyyli|-1,3-dihydro-2H-i ndol-2-onin valmistamiseksi ja uusi välituote
MX154758A (es) Procedimiento para preparacion de derivados de succinimida
EE03194B1 (et) Ühendid, nende kasutamine magustavate toimeainetena ja nende valmistamise meetod
EA200000334A1 (ru) Производные карбоксамидотиазолов, их получение, содержащие их фармацевтические композиции
PT96890A (pt) Processo para a preparacao de novos derivados com estrutura naftalenica e de composicoes farmaceuticas que os contem
BR9611618A (pt) Composto processo para sua preparação composição farmacêutica e utilização de um compostos
MX9300821A (es) Compuestos hipolipidemicos.
ATE29255T1 (de) Succinimid-derivate und deren herstellung.
SE503618C2 (sv) Antihyperkolesterolemiska tetrazolföreningar
BR1100061A (pt) Composto, processo para a preparação do mesmo, composição e uso dos mesmos
DK161385C (da) Analogifremgangsmaade til fremstilling af theophyllinylalkyloxadiazoler eller fysiologisk acceptable additionssalte deraf
DK400781A (da) Fremgangsmaade til fremstilling af 2-(1,4-benzodioxan-2-ylalkyl) imidazoler
DK0594666T3 (da) Fremgangsmåde til fremstilling af sertralin
EA199600007A2 (ru) Новые трициклические производные, способ их получения, способы получения оптически активных или рацемических колхицина и тиоколхицина, их аналогов или производных с использованием трициклических соединений и промежуточные продукты синтеза
ES2028886T3 (es) Procedimiento de preparacion de un derivado ester heterociclico disimetrico del acido 1,4-dihidropiridina-3,5-dicarboxilico.
ES2074343T3 (es) Nuevas feniletanolamino- y feniletanolaminometil-tetralinas, procedimiento para su preparacion, intermediarios en este procedimiento y composiciones farmaceuticas que los contienen.
DK148804C (da) Fremgangsmaade til fremstilling af 1,2,3,4-tetrahydroquinolin-4-oner
SE8207294D0 (sv) 1,4-tiazankarboxylsyraderivat, deras framstellning och anvendning och kompositioner vari dessa derivat ingar
SE8406046D0 (sv) New azabiocyclic compounds and a process for the preparation thereof
SE7905060L (sv) Nya 1-pyrrol- och 1-pyrrolidin-karboxylsyraderivat och sett for framstellning derav
NO980353D0 (no) Nye koblingsmidler, deres fremstilling samt hårfarvemidler inneholdende koblingsmidlene
ES477709A1 (es) Procedimiento de preparacion de nuevos compuestos cis- y trans-1,5-benzotiacepinicos.
ES8106526A1 (es) Procedimiento de preparacion de nuevos derivados 15-hidro- xi-e-homoeburnanos halogenados racemicos y opticamente acti-vos y de sus sales de adicion acidas
SE8601798D0 (sv) Process for the preparation of eburnamenine derivatives
DK0555283T3 (da) Mellemprodukter ved fremstillingen af 4,5-difluoranthranilinsyre